Article info

Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis

Authors

  • Rovina Ruslami Division of Pharmacology and Therapy, Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia PubMed articlesGoogle scholar articles
  • Fajri Gafar Unit of PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Vycke Yunivita Division of Pharmacology and Therapy, Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia PubMed articlesGoogle scholar articles
  • Ida Parwati Department of Clinical Pathology, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin Hospital, Bandung, Indonesia PubMed articlesGoogle scholar articles
  • Ahmad R Ganiem Department of Neurology, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin Hospital, Bandung, Indonesia PubMed articlesGoogle scholar articles
  • Rob E Aarnoutse Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Bob Wilffert Unit of PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Jan-Willem C Alffenaar School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia Westmead Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Heda M Nataprawira Division of Pediatric Respirology, Department of Child Health, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin Hospital, Bandung, Indonesia PubMed articlesGoogle scholar articles
  1. Correspondence to Fajri Gafar, Unit of PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen 9713 AV, The Netherlands; f.gafar{at}rug.nl; fajri.gafar{at}gmail.com
View Full Text

Citation

Ruslami R, Gafar F, Yunivita V, et al
Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis

Publication history

  • Received December 14, 2020
  • Accepted June 14, 2021
  • First published June 28, 2021.
Online issue publication 
January 08, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.